NCT06841627

Brief Summary

Chronic headaches are associated with changes in brain structure and function that may be associated with increased suffering and disability. Understanding how Osteopathic Manipulative Therapy (OMT) affects these changes would reveal new insight into how the brain processes pain and returns to normal function. Also, demonstrating these changes would provide evidence regarding how OMT causes a reduction in pain and disability, supporting the recommendation for OMT as a primary treatment option for headaches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

August 5, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2026

Completed
Last Updated

May 6, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

February 19, 2025

Last Update Submit

May 5, 2026

Conditions

Keywords

MigraineHeadachesOsteopathic Manipulative TreatmentBrainOMT

Outcome Measures

Primary Outcomes (1)

  • Brain Structural and Functional Changes

    Structural MRI will assess physical changes in brain anatomy, including differences in the size, shape, or density of specific brain regions. For example, changes in gray matter volume or white matter integrity may indicate neuroplasticity changes response to an OMT. Functional MRI (fMRI) will measure brain activity by detecting changes in blood flow within the central pain network. When a specific brain region becomes more active, it requires more oxygen, which fMRI can detect. This will help determine whether the intervention alters brain function, such as increased activation in areas involved in movement, memory, or pain processing. Magnetic Resonance Spectroscopy (MRS), unlike standard MRI, which provides images of brain structures, will analyze chemical changes in the brain. It detects levels of important brain metabolites involved in neural signaling neuronal health.

    From enrollment to the end of treatment at 5 weeks

Secondary Outcomes (4)

  • Headache Impact Test - 6 (HIT-6)

    From enrollment to the end of treatment at 5 weeks

  • Short Form -36 (SF-36)

    From enrollment to the end of treatment at 5 weeks

  • Depression Anxiety and Stress Scale 21 (DASS-21)

    From enrollment to the end of treatment at 5 weeks

  • Headache intensity

    From enrollment to the end of treatment at 5 weeks

Study Arms (1)

OMT Treatment Group

EXPERIMENTAL
Other: Osteopathic Manipulative Therapy

Interventions

Evaluation looking for Somatic Dysfunction (SD) involving the head, neck, upper thoracic spine, rib cage and sacroiliac joint. OMT techniques will include a mix of the following: Osteopathic Cranial Manipulative Medicine, Muscle Energy Technique, Facilitated Positional Release, Indirect Myofascial Release, and Counterstrain.

OMT Treatment Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • current diagnosis of primary headache (migraine, tension-type, cluster) from a healthcare provider
  • have experienced at least one headache episode a month for the previous 1 year (or longer)
  • age of PH onset was less than 50 years, currently taking medication for headaches.

You may not qualify if:

  • presence of headaches due to some other underlying medical condition (secondary headaches)
  • traumatic brain injury
  • fibromyalgia, epilepsy
  • diagnosis of a neurodegenerative disorder
  • history of brain tumor or cancer
  • history of cervical radiculopathy (pinched nerve in the neck)
  • currently undergoing manual therapy type treatment or have a a treatment within 2 weeks of enrollment(chiropractic, OMT, massage, PT)
  • currently pregnant
  • have had an injection to treat headaches within the previous 3 months from study enrollment
  • contraindications to MRI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Auburn University MRI Center and Edward Via College of Medicine

Auburn, Alabama, 36832, United States

Location

MeSH Terms

Conditions

Migraine DisordersCluster HeadacheHeadache

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrigeminal Autonomic CephalalgiasPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Daniel Cawley, DC

    Edward Via College of Osteopathic Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2025

First Posted

February 24, 2025

Study Start

August 5, 2025

Primary Completion

October 1, 2025

Study Completion

May 5, 2026

Last Updated

May 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations